Mamlins, Eduards http://orcid.org/0000-0002-3581-2282
Scharbert, Lara
Cardinale, Jens
Krotov, Maria
Winter, Erik
Rathke, Hendrik
Strodel, Birgit
Ankrah, Alfred O.
Sathekge, Mike
Haberkorn, Uwe
Kratochwil, Clemens
Giesel, Frederik L.
Funding for this research was provided by:
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
Article History
Received: 6 October 2023
Revised: 22 November 2023
Accepted: 24 November 2023
First Online: 8 December 2023
Declarations
:
: All procedures were carried out in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The ethical Committee of the University Hospital Heidelberg approved the retrospective Evaluation (permission S-732-18).
: FLG, UH, and JC have patent applications for PSMA-1007. FLG is also advisor at ABX Advanced Biochemical Compound, Telix Pharmaceuticals and SOFIE Biosciences. FLG, CK, JC, and UH are inventors of PSMA-GCK01 which is in the global patent applications process and owned by Telix Pharmaceuticals Limited. The other authors declare no conflict of interest regarding this manuscript.